Almonty Prepares for Russell 1000 as Molybdenum Drilling Bolsters South Korea’s Critical Mineral Push
Published on 06/20/2026 at 20:33 | Redaktion boerse-global.de
The numbers tell a compelling story. Almonty Industries closed the week at CAD 26.67, up nearly 8 percent, with shares more than doubling since January and gaining almost 461 percent over the past twelve months. But the real action lies in two converging events that promise to reshape the company’s investor base and resource profile in the weeks ahead.
On June 29, Almonty will join the Russell 1000 Index, the large-cap benchmark for U.S. equities, alongside the broader Russell 3000. That isn’t a mere listing ceremony. With roughly $12.2 trillion in passively managed capital benchmarked against Russell indices, index-reconstitution rules will force funds to hold Almonty shares regardless of sentiment or analyst ratings. The structural buying pressure is automatic — and timed.
That index entry arrives as Almonty’s operational pivot to molybdenum gathers pace. On June 16, the company reported that 37 percent of its planned drilling program at the Sangdong Molybdenum Project in South Korea is complete. The program covers 26 boreholes totaling about 12,000 meters, and assays so far confirm historical grades. The consistency reinforces management’s confidence in the deposit’s size and quality — a critical signal for markets hungry for supply visibility.
The strategic urgency is geopolitical. South Korea’s national molybdenum reserves have fallen to critical levels, and the government has issued public notices urging private companies to secure the metal independently. Molybdenum, which enhances heat and corrosion resistance in steel and specialty alloys, is essential for aerospace, defense, nuclear energy, and petrochemicals. The spot price has climbed 23.5 percent year-over-year to CNY 592.34 per kilogram. Almonty’s accelerated drilling positions Sangdong as a domestic solution for South Korea’s semiconductor and defense industries.
Should investors sell immediately? Or is it worth buying Almonty?
The company’s core tungsten business provides the operational heft. First-quarter 2026 revenue surged 221 percent to $25.4 million, while operating cash flow flipped from negative $4.4 million to positive $9.7 million. Net loss narrowed sharply to $5.3 million from $34.6 million a year earlier. Cash on hand stood at $259.9 million as of March 31. The tungsten price has more than quintupled since China imposed export licensing for strategic minerals in February 2025, and since mid-April the average price has stayed above $3,000 per metric ton unit.
Sangdong’s tungsten mine is already in Phase 1, processing roughly 640,000 tonnes of ore annually, with Phase 2 expansion slated for 2027 — doubling capacity to 1.2 million tonnes.
Analysts, however, are divided. Far East Capital recommended selling Almonty shares on June 18, arguing that after the parabolic run, the company needs aggressive earnings growth to justify the current market capitalization. The counterargument, published the following day, points out that Almonty has been valued primarily as a tungsten play, while the molybdenum project could serve as a second value driver not yet fully priced in. A caveat was raised about dilution from prior capital raisings.
Almonty at a turning point? This analysis reveals what investors need to know now.
The technical picture suggests a market catching its breath. Shares trade roughly 2 percent below the 50-day moving average of CAD 27.21, and about 20 percent off the 52-week high of CAD 33.35 hit in mid-April. The relative strength index at 53 sits in neutral territory. Yet the longer-term trend remains intact: the stock is more than 50 percent above its 200-day average. With annualized 30-day volatility approaching 99 percent, swings in both directions are the new normal.
The coming weeks deliver two measurable milestones: additional assay results from the molybdenum drilling campaign and the Russell index reconstitution. Both have the potential to expand Almonty’s investor base — one through data, the other through mandate.
Ad
Almonty Stock: New Analysis - 20 June
Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
